Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Nov 23, 2022

Accession no.
0001209191-22-058551
Filed
Nov 23, 2022, 7:10 AM ET
Trade date
Nov 22, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions. Open-market purchases total $446.7K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 22, 2022Common StockPPurchaseAcquired+34,247$1.48+$50,514.33198,565,941Indirect
Nov 22, 2022Common StockPPurchaseAcquired+58,006$1.48+$85,848.88198,623,947Indirect
Nov 22, 2022Common StockPPurchaseAcquired+1,200$1.48+$1,779198,625,147Indirect
Nov 22, 2022Common StockPPurchaseAcquired+93,500$1.49+$138,847.5198,718,647Indirect
Nov 22, 2022Common StockPPurchaseAcquired+11,551$1.49+$17,210.99198,730,198Indirect
Nov 22, 2022Common StockPPurchaseAcquired+75,496$1.50+$113,244198,805,694Indirect
Nov 22, 2022Common StockPPurchaseAcquired+6,345$1.51+$9,549.23198,812,039Indirect
Nov 22, 2022Common StockPPurchaseAcquired+19,655$1.51+$29,679.05198,831,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)